Closing the RCT Gap—A Large Meta-Analysis on the Role of Surgery in Stage I–III Small Cell Lung Cancer Patients
F Doerr, S Stange, S Salamon, K Grapatsas, N Baldes… - Cancers, 2024 - mdpi.com
Simple Summary Despite guidelines recommending surgery as part of treatment for stage I
small cell lung cancer (SCLC), its application remains inconsistent, and its role in stages II …
small cell lung cancer (SCLC), its application remains inconsistent, and its role in stages II …
Prognostic signature for lung adenocarcinoma patients based on cell-cycle-related genes
W Jiang, J Xu, Z Liao, G Li, C Zhang… - Frontiers in cell and …, 2021 - frontiersin.org
Objective To screen lung adenocarcinoma (LUAC)-specific cell-cycle-related genes
(CCRGs) and develop a prognostic signature for patients with LUAC. Methods The …
(CCRGs) and develop a prognostic signature for patients with LUAC. Methods The …
Redefining the role of surgery in early small-cell lung cancer
F Doerr, S Stange, M Michel… - … Archives of Surgery, 2022 - Springer
Purpose Resection is guideline recommended in stage I small-cell lung cancer (SCLC) but
not in stage II. In this stage, patients are treated with a non-surgical approach. The aim of this …
not in stage II. In this stage, patients are treated with a non-surgical approach. The aim of this …
Additional Postoperative Radiotherapy Prolonged the Survival of Patients with I‐IIA Small Cell Lung Cancer: Analysis of the SEER Database
J Li, Z Zeng, Z Huang, Y Gong, C Xie - Journal of Oncology, 2022 - Wiley Online Library
Purpose. Complete resection and adjuvant chemotherapy are recommended as the
standard strategy for patients with stage I‐IIA small cell lung cancer (SCLC). However, the …
standard strategy for patients with stage I‐IIA small cell lung cancer (SCLC). However, the …
[HTML][HTML] Prognostic factors of patients with small cell lung cancer after surgical treatment
C Zeng, N Li, F Li, P Zhang, K Wu, D Liu… - Annals of Translational …, 2021 - ncbi.nlm.nih.gov
Background The current National Comprehensive Cancer Network guidelines recommend
surgical treatment for patients with stages I–IIA small cell lung cancer (SCLC), but it still …
surgical treatment for patients with stages I–IIA small cell lung cancer (SCLC), but it still …
[HTML][HTML] Treatment Patterns and Survival Outcomes in Patients With Stage T1-2N0M0 Small Cell Lung Cancer Undergoing Surgery: A Retrospective Cohort Study
JQ Huang, HW Liang, Y Liu, L Chen, S Pei… - World Journal of …, 2024 - ncbi.nlm.nih.gov
Background The aim of the study was to delineate the treatment modalities and survival
outcomes in patients with stage T1-2N0M0 small cell lung cancer (SCLC) who underwent …
outcomes in patients with stage T1-2N0M0 small cell lung cancer (SCLC) who underwent …
[HTML][HTML] Impact of examined lymph node count on survival outcomes in patients with stage T1-2N0M0 small cell lung cancer undergoing surgery: A retrospective …
XB Wan, HW Liang, Y Liu, W Huang, XB Pan - Medicine, 2024 - journals.lww.com
To explore the relationship between the count of examined lymph nodes (ELNs) and
survival outcomes in patients with stage T1-2N0M0 small cell lung cancer (SCLC) after …
survival outcomes in patients with stage T1-2N0M0 small cell lung cancer (SCLC) after …
[HTML][HTML] Predictors for survival in patients with bone metastasis of small cell lung cancer: a population-based study
MF Xue, G Chen, XG Chen, JY Hu - Medicine, 2021 - journals.lww.com
Predictors for survival in patients with bone metastasis of... : Medicine Predictors for survival in
patients with bone metastasis of small cell lung cancer: A population-based study : Medicine …
patients with bone metastasis of small cell lung cancer: A population-based study : Medicine …
The presence of spread through air spaces predicts poor postoperative survival in pathological IA stage non-small cell lung cancer patients: A meta-analysis
J Lv, P Chen, J Wu, Z Wen, J Wei, C Zhao - 2023 - researchsquare.com
Purpose Spread through air spaces (STAS) is an independent predictive indicator of poor
survival in intermediate and advanced non-small cell lung cancer (NSCLC). However …
survival in intermediate and advanced non-small cell lung cancer (NSCLC). However …